Invesco’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $20.6K | Sell |
|
|||||
|
2023
Q4 | $11.8K | Sell |
|
|||||
|
2023
Q3 | $30.5K | Buy |
|
|||||
|
2023
Q2 | $59.4K | Buy |
|
|||||
|
2023
Q1 | $86.7K | Buy |
|
|||||
|
2022
Q4 | $97.6K | Sell |
|
|||||
|
2022
Q3 | $809K | Buy |
|
|||||
|
2022
Q2 | $693K | Sell |
|
|||||
|
2022
Q1 | $842K | Buy |
|
|||||
|
2021
Q4 | $920K | Buy |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $296K | Sell |
|
|||||
|
2021
Q1 | $1.01M | Sell |
|
|||||
|
2020
Q4 | $2.34M | Buy |
|
|||||
|
2020
Q3 | $700K | Buy |
|
|||||
|
2020
Q2 | $747K | Buy |
|